More on ABBV
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $243.87 |
|
|||
| Open | $243.62 | ||||
| 52 Wk High | $68.12 | ||||
| 52 Wk Low | $50.71 | ||||
| Day High | $246.76 | ||||
| Day Low | $241.95 | ||||
| P/E | 53.37 | ||||
| EPS | $4.61 | ||||
| Volume | 4,930,689 | ||||
- Form 424B5 AbbVie Inc.
- Form 8-K AbbVie Inc. For: Aug 04
- Erste Group Upgrades Abbvie (ABBV) to Buy
- Form FWP AbbVie Inc. Filed by: AbbVie Inc.
- Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
- Form 424B5 AbbVie Inc.
- FDA accepts AbbVie's Botox Cosmetic application for jaw slimming use
- Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
- Abbvie (ABBV) PT Raised to $288 at Guggenheim
- Form 10-Q AbbVie Inc. For: Jun 30
Entities mentioned with ABBV
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Dividend | View Related Stories »
- Show More...
